Jason Butler
Stock Analyst at Citizens JMP
(4.84)
# 426
Out of 4,993 analysts
717
Total ratings
51.8%
Success rate
19.6%
Average return
Main Sectors:
Stocks Rated by Jason Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARGX argenx SE | Reiterated: Buy | $932 → $1,200 | $988.20 | +21.43% | 44 | Aug 18, 2026 | |
| LONA LeonaBio | Reiterated: Buy | $18 → $17 | $6.33 | +168.56% | 36 | Aug 17, 2026 | |
| CYTK Cytokinetics | Reiterated: Buy | $96 → $110 | $67.56 | +62.82% | 63 | Aug 7, 2026 | |
| HALO Halozyme Therapeutics | Reiterated: Buy | $92 → $93 | $111.45 | -16.55% | 49 | Aug 7, 2026 | |
| ZVRA Zevra Therapeutics | Reiterated: Buy | $25 → $28 | $11.67 | +139.93% | 11 | Aug 6, 2026 | |
| ACAD ACADIA Pharmaceuticals | Reiterated: Buy | $35 → $36 | $26.40 | +36.39% | 49 | Aug 5, 2026 | |
| RZLT Rezolute | Upgraded: Buy | $11 | $3.91 | +181.33% | 33 | Jun 3, 2026 | |
| ABVX ABIVAX Société Anonyme | Reiterated: Buy | $131 → $187 | $103.45 | +80.76% | 14 | Jun 2, 2026 | |
| GHRS GH Research | Reiterated: Buy | $42 → $39 | $27.93 | +39.63% | 24 | May 15, 2026 | |
| AVTX Avalo Therapeutics | Reiterated: Buy | $62 → $55 | $16.17 | +240.14% | 3 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $11 | $7.70 | +42.86% | 49 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $20 | $8.51 | +135.02% | 27 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $14 | $3.69 | +279.92% | 19 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $18 | $3.44 | +423.26% | 2 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $10 | $4.41 | +126.76% | 19 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $8.05 | +136.02% | 1 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $77 → $80 | $39.66 | +101.71% | 6 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $12 | $4.78 | +151.05% | 53 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $22 | $7.77 | n/a | 43 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 → $38 | $21.58 | n/a | 29 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0004 | n/a | 31 | Dec 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0112 | n/a | 38 | Dec 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.1814 | n/a | 13 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $31.00 | n/a | 8 | Jun 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.90 | n/a | 9 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 5 | Sep 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.71 | n/a | 5 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 → $70 | $78.08 | n/a | 3 | Jan 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.83 | n/a | 7 | Sep 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.51 | n/a | 3 | Mar 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 | $5.16 | n/a | 8 | Feb 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $3.61 | n/a | 1 | Oct 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $269.01 | n/a | 1 | Jul 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.50 | n/a | 5 | May 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $2 | $39.55 | n/a | 2 | Aug 16, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $11.37 | n/a | 1 | May 22, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $16.11 | n/a | 2 | May 6, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.26 | n/a | 1 | Mar 26, 2013 |
argenx SE
Aug 18, 2026
Reiterated: Buy
Price Target: $932 → $1,200
Current: $988.20
Upside: +21.43%
LeonaBio
Aug 17, 2026
Reiterated: Buy
Price Target: $18 → $17
Current: $6.33
Upside: +168.56%
Cytokinetics
Aug 7, 2026
Reiterated: Buy
Price Target: $96 → $110
Current: $67.56
Upside: +62.82%
Halozyme Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $92 → $93
Current: $111.45
Upside: -16.55%
Zevra Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $25 → $28
Current: $11.67
Upside: +139.93%
ACADIA Pharmaceuticals
Aug 5, 2026
Reiterated: Buy
Price Target: $35 → $36
Current: $26.40
Upside: +36.39%
Rezolute
Jun 3, 2026
Upgraded: Buy
Price Target: $11
Current: $3.91
Upside: +181.33%
ABIVAX Société Anonyme
Jun 2, 2026
Reiterated: Buy
Price Target: $131 → $187
Current: $103.45
Upside: +80.76%
GH Research
May 15, 2026
Reiterated: Buy
Price Target: $42 → $39
Current: $27.93
Upside: +39.63%
Avalo Therapeutics
May 14, 2026
Reiterated: Buy
Price Target: $62 → $55
Current: $16.17
Upside: +240.14%
May 14, 2026
Reiterated: Buy
Price Target: $9 → $11
Current: $7.70
Upside: +42.86%
May 8, 2026
Reiterated: Buy
Price Target: $19 → $20
Current: $8.51
Upside: +135.02%
Apr 15, 2026
Initiated Coverage: Buy
Price Target: $14
Current: $3.69
Upside: +279.92%
Mar 26, 2026
Reiterated: Buy
Price Target: $19 → $18
Current: $3.44
Upside: +423.26%
Feb 26, 2026
Reiterated: Buy
Price Target: $8 → $10
Current: $4.41
Upside: +126.76%
Nov 25, 2025
Initiated Coverage: Buy
Price Target: $19
Current: $8.05
Upside: +136.02%
Nov 7, 2025
Reiterated: Buy
Price Target: $77 → $80
Current: $39.66
Upside: +101.71%
Oct 9, 2025
Reiterated: Buy
Price Target: $9 → $12
Current: $4.78
Upside: +151.05%
Sep 9, 2025
Reiterated: Buy
Price Target: $19 → $22
Current: $7.77
Upside: n/a
May 7, 2025
Reiterated: Buy
Price Target: $42 → $38
Current: $21.58
Upside: n/a
Dec 27, 2024
Rated: Hold
Price Target: n/a
Current: $0.0004
Upside: n/a
Dec 27, 2024
Downgraded: Hold
Price Target: n/a
Current: $0.0112
Upside: n/a
Nov 3, 2023
Rated: Hold
Price Target: n/a
Current: $0.1814
Upside: n/a
Jun 9, 2023
Rated: Hold
Price Target: n/a
Current: $31.00
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $6.90
Upside: n/a
Sep 3, 2021
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Aug 16, 2021
Reiterated: Hold
Price Target: n/a
Current: $2.71
Upside: n/a
Jan 9, 2020
Reiterated: Buy
Price Target: $58 → $70
Current: $78.08
Upside: n/a
Sep 5, 2019
Downgraded: Hold
Price Target: n/a
Current: $3.83
Upside: n/a
Mar 28, 2019
Downgraded: Hold
Price Target: n/a
Current: $3.51
Upside: n/a
Feb 14, 2019
Reiterated: Buy
Price Target: $52
Current: $5.16
Upside: n/a
Oct 18, 2016
Reiterated: Buy
Price Target: $17
Current: $3.61
Upside: n/a
Jul 28, 2016
Reiterated: Buy
Price Target: $61
Current: $269.01
Upside: n/a
May 10, 2016
Reiterated: Hold
Price Target: n/a
Current: $3.50
Upside: n/a
Aug 16, 2013
Reiterated: Buy
Price Target: $6 → $2
Current: $39.55
Upside: n/a
May 22, 2013
Initiated Coverage: Hold
Price Target: n/a
Current: $11.37
Upside: n/a
May 6, 2013
Downgraded: Hold
Price Target: n/a
Current: $16.11
Upside: n/a
Mar 26, 2013
Downgraded: Hold
Price Target: n/a
Current: $1.26
Upside: n/a